



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Tuesday,
                        12 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    HEALTH AND FAMILY WELFARE






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

2290






                                    ANSWERED ON: 
                                

10.12.2021






Research by ICMR on Pandemic Diseases




Thalikkottai Rajuthevar Baalu














                        Will the Minister of





HEALTH AND FAMILY WELFARE


                        be pleased to state:-















                                                    (a) the details of research carried out and funds utilized so far by the Indian Council of Medical Research(ICMR) on pandemic diseases such as COVID-19;	(b) the number of medicinal formulations developed and patents obtained as on date; and	(c) the details of financial and socio-economic benefits derived by ICMR and the country from such research?	






ANSWER




                                                        THE HON’BLE MINISTER OF STATE FOR HEALTH AND FAMILY WELFAREDR. BHARATI PRAVIN PAWAR(a) to (c): The major research activities carried out by Indian Council of Medical Research (ICMR) include development and standardization of testing kits,Nationwide serosurvey to determine the seroprevalence of SARS-CoV-2,isolation of SARS-CoV-2 virus, COVID-19 Vaccine trials and was involved in WHO solidarity trials to see the efficacy of repurpose drug for their efficacy and use for COVID-19. ICMR also conducted Plasma Therapy trials (PLACID). Based on this research, an advisory and guidelines were issued by the Government for appropriate use of repurpose drugs in COVID-19.Funds amounting to Rs. 1504.29 crore have been utilized by ICMR for related research.The details of medicinal formulation developed and patents obtained are as follows:i.	ICMR Institutes have six patents related to various diagnostic kits of COVID-19ii.	ICMR has also filed a joint patent for monoclonal antibodies for COVID-19 along with Department of Biotechnology –International Centre for Genetic Engineering and Biotechnology (DBT-ICGEB), Delhi.iii.	ICMR and Bharat Biotech International ltd. (BBIL) have made an agreement for development of Covaxin.The details of financial and socio-economic benefits are as follows: i.	The indigenous COVID-19 vaccine, Covaxin, developed by ICMR and BBIL has helped in vaccination of crores of individuals. This exemplary public private partnership has helped in showcasing the strength of Indian science to the entire world. ICMR has been receiving royalty from BBIL in phases.ii.	The PLACID trial conducted by ICMR demonstrated the futility of indiscriminate use of convalescent plasma in treatment of COVID-19. This has helped in substantial reduction of the cost of treatment.iii.	The initiative taken by ICMR/DHR to promote production and validation of indigenous diagnostic kits for COVID-19 has helped in drastically reducing the cost of testing. RTPCR testing has now become very affordable for all citizens of India.iv.	Strengthening and hand-holding of indigenous manufacturers for production of VTM, swabs, RNA extraction kits, RTPCR and RAT kits has helped in strengthening the capacity of MSMEs in India.v.	Evidence based advisories issued by ICMR from time to time have helped in rationalizing treatment costs for COVID-19 in India.****
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113227081







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







